Shares of Atrinsic Inc. (NASDAQ:PTIX – Get Free Report) dropped 14.3% during mid-day trading on Friday. The stock traded as low as $0.5355 and last traded at $0.54. 8,460 shares were traded during mid-day trading, a decline of 67% from the average daily volume of 25,480 shares. The stock had previously closed at $0.63.
Atrinsic Stock Performance
The stock’s 50-day moving average is $0.80 and its 200 day moving average is $0.57. The firm has a market cap of $977,400.00, a P/E ratio of -0.07 and a beta of 1.94.
Atrinsic Company Profile
Atrinsic, Inc was an online marketing and digital media company that developed and operated consumer-focused websites and provided performance-based marketing services. Its activities included customer acquisition, lead generation, online advertising and related digital commerce initiatives.
The company’s operations were primarily conducted through internet-based channels and were aimed at connecting consumers with products and services offered by third parties. Publicly available information about Atrinsic’s specific brands, geographic markets and management team is limited.
Atrinsic later changed its corporate direction and became Protagenic Therapeutics, Inc, a biotechnology company focused on developing therapeutics based on neuropeptides.
Featured Articles
- Five stocks we like better than Atrinsic
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Atrinsic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrinsic and related companies with MarketBeat.com's FREE daily email newsletter.
